S-Bank Fund Management’s Gilead Sciences GILD Stock Holding History

S-Bank Fund Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Buy	10,870 +10,061	+1,244%	+$1.33M	0.19%	81
2026 Q1	$113K	Sell	809 -30	-4%	-$4.2K	0.02%	160
2025 Q4	$103K	Sell	839 -454	-35%	-$55.2K	0.01%	161
2025 Q3	$144K	Sell	1,293 -16	-1%	-$1.82K	0.02%	182
2025 Q2	$145K	Sell	1,309 -127	-9%	-$13.5K	0.02%	185
2025 Q1	$161K	Buy	+1,436	New	+$148K	0.03%	162

Other funds holding GILD

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

S-Bank Fund Management's GILD Position: Q2 2026 in Review

S-Bank Fund Management increased its Gilead Sciences (GILD) stake by 1,244% in Q2 2026, buying an estimated $1.33M and bringing the position to 10,870 shares worth $1.37M. The position accounts for 0.19% of the portfolio, ranked #81.

S-Bank Fund Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. 1,245 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

S-Bank Fund Management held 10,870 shares of Gilead Sciences worth $1.37M as of Q2 2026.
S-Bank Fund Management bought 10,061 Gilead Sciences shares in Q2 2026, an estimated $1.33M.
Gilead Sciences made up 0.19% of S-Bank Fund Management's portfolio in Q2 2026, its #81 holding.
S-Bank Fund Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
1,245 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.